WF
GILD icon

Wayfinding Financial’s Gilead Sciences GILD Stock Holding History

Wayfinding Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Buy
3,101
+153
+5% +$20.2K 0.15% 102
2026
Q1 		$410K Buy
2,948
+37
+1% +$5.18K 0.18% 84
2025
Q4 		$357K Buy
2,911
+172
+6% +$20.9K 0.15% 92
2025
Q3 		$304K Buy
2,739
+5
+0.2% +$568 0.13% 103
2025
Q2 		$313K Sell
2,734
-131
-5% -$13.9K 0.14% 96
2025
Q1 		$321K Buy
2,865
+283
+11% +$29.2K 0.14% 93
2024
Q4 		$238K Buy
+2,582
New +$232K 0.13% 113
2024
Q1 		– Sell
-2,784
Closed -$225K – 127
2023
Q4 		$225K Sell
2,784
-578
-17% -$45K 0.15% 98
2023
Q3 		$249K Buy
3,362
+219
+7% +$16.8K 0.19% 92
2023
Q2 		$241K Sell
3,143
-121
-4% -$9.65K 0.17% 98
2023
Q1 		$270K Buy
+3,264
New +$270K 0.21% 85

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wayfinding Financial's GILD Position: Q2 2026 in Review

Wayfinding Financial increased its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, buying an estimated $20.2K and bringing the position to 3,101 shares worth $391K. The position accounts for 0.15% of the portfolio, ranked #102.

Wayfinding Financial first reported a position in GILD in Q1 2023 and has held it in 11 quarters since. The position peaked at $410K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wayfinding Financial held 3,101 shares of Gilead Sciences worth $391K as of Q2 2026.
  • Wayfinding Financial bought 153 Gilead Sciences shares in Q2 2026, an estimated $20.2K.
  • Gilead Sciences made up 0.15% of Wayfinding Financial's portfolio in Q2 2026, its #102 holding.
  • Wayfinding Financial first reported a position in Gilead Sciences in Q1 2023 and has held it in 11 quarters since.
  • Wayfinding Financial's Gilead Sciences position peaked at $410K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wayfinding Financial's 13F filing for Q2 2026, filed 13 Aug 2026.